N‐acetyl‐b‐D ‐glucosaminidase: A potential cardiorenal biomarker with a relevant impact on ICD shock therapies and mortality-Reference-Cited by-同舟云学术

N‐acetyl‐b‐D ‐glucosaminidase: A potential cardiorenal biomarker with a relevant impact on ICD shock therapies and mortality

Published:2020-09-06 Issue:12 Volume:25 Page:888-896
ISSN:1320-5358
Container-title:Nephrology
language:en
Short-container-title:Nephrology

Author:

Allgaier Raphael¹^ORCID,Strack Christina¹,Wallner Stefan²,Hubauer Ute¹,Uecer Ekrem¹,Lehn Petra²,Keyser Andreas³,Luchner Andreas⁴,Maier Lars¹,Jungbauer Carsten¹

Affiliation:

1. Department of Internal Medicine II University Medical Center Regensburg Regensburg Germany

2. Department of Clinical Chemistry and Laboratory Medicine University Medical Center Regensburg Regensburg Germany

3. Department of Cardiothoracic Surgery University Medical Center Regensburg Regensburg Germany

4. Department of Cardiology Hospital Barmherzige Brüder Regensburg Regensburg Germany

Publisher

Wiley

Subject

Nephrology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nep.13776

Reference32 articles.

1. Sudden cardiac death and arrhythmias;Srinivasan NT;Arrhythmia Electrophysiol Rev,2018

2. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

3. Risk stratification for sudden cardiac death: current status and challenges for the future

4. NT-proBNP

5. Cardiorenal and renocardiac syndromes: the need for a comprehensive classification and consensus;Ronco C;Nat Clin Pract Nephrol,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Expression of Angiopoetin-Like Protein-4 and Kidney Injury Molecule-1 as Preliminary Diagnostic Markers for Diabetes-Related Kidney Disease: A Single Center-Based Cross-Sectional Study;Journal of Personalized Medicine;2023-03-24

2. NAG: potential cardiorenal biomarker indicates the progression of chronic kidney disease in implantable cardioverter defibrillator patients, contrary to KIM-1;Biomarkers in Medicine;2022-03